December 2021 Vol 14, No 4
10
September 2021 Vol 14, No 3
5
2019 Payers' Guide Mid-Year Addendum
11
Annual Index
2
Appendix
1
April 2008, Vol 1, No 3
9
April 2013 Vol 6 No 3 Payers’ Guide to New FDA Approvals
20
April 2014 Vol 7, No 2
4
April 2015, Vol 8, No 2
4
April 2016 Vol 9, No 2
4
April 2017 Vol 10, No 2
5
April 2018 Vol 11, No 2
5
April 2019 Vol 12, No 2
4
April/May 2009, Vol 2, No 3
8
August 2009, Vol 2, No 5, SPECIAL ISSUE
0
August 2011 Vol 4, No 4, Special Issue
30
August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective
33
August 2012, Vol 5, No 5, Special Issue ADA 2012 Highlights
32
August 2013 Vol 6, No 6 Special Issue
34
August 2013, Vol 6 ADA 2013 Highlights
19
August 2014 Vol 7, No 5
5
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
32
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
37
August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology
32
August 2017, Vol 10, Special Issue: Payers’ Perspectives in Oncology: ASCO 2017 Highlights
27
August 2017, Vol 10, Supplement 1: Value-Based Perspectives on the Management of Allergic Rhinitis
0
August 2018 Vol 11, Special Issue
24
August 2019, Vol 12, Special Issue: Payers' Perspectives In Oncology: ASCO 2019 Highlights
30
August 2020 Vol 13, Eleventh Annual Payers' Guide
8
August 2020 Vol 13, Special Issue: Payers' Perspectives in Oncology
30
August 2021 Vol 14, Special Issue: Payers' Perspectives in Oncology
14
AVBCC Webcast Series
25
Conference Correspondent
242
Continuing Education
4
December 2014 Vol 7, No 9
4
December 2015 Vol 8, No 9
6
December 2016 Vol 9, No 9
6
December 2016 Vol 9, Special Issue: Payers’ Perspectives In Oncology: AVBCC 2016 Highlights
20
December 2017 Vol 10, No 9
5
December 2018 - MOA Magnifier
0
December 2018 Vol 11, No 9
8
December 2019 Vol 12, No 8
3
December 2020
0
December 2021 Twelfth Annual Payers' Guide
5
December 2022 Vol 15, No 4
8
Drug Updates 2015
0
Faculty Perspectives in Chronic Pain: Epidemiologic Assessments of Abuse-Deterrent Formulations
4
Faculty Perspectives in Chronic Pain: In Vitro and Clinical Assessments of Abuse-Deterrent Formulations for Chronic Pain
4
Faculty Perspectives in Chronic Pain: Socioeconomic Burden of Chronic Pain
4
Faculty Perspectives in Chronic Pain: Solutions to Public Health Issues in Chronic Pain
4
Faculty Perspectives in Chronic Pain:Utilizing Pharmacogenomics When Selecting Personalized Medicine for Patients with Chronic Pain
4
Faculty Perspectives: Advancing Anticoagulation Safety
0
Faculty Perspectives: Coping with Agitation Associated with Schizophrenia and Bipolar Disorder: How Can Healthcare Professionals Help Their Patients?
4
Faculty Perspectives: Similarities and Differences in Agitation Associated with Schizophrenia and Bipolar Disorder
4
Faculty Perspectives: The Spectrum of Agitation Associated with Schizophrenia and Bipolar Disorder
4
February 2008, Vol 1, No 1
9
February 2010, Vol 3, No 1 SPECIAL ISSUE
0
February 2012 Vol 5, No 1, Special Issue
29
February 2013 Vol 6, No 1, Special Issue
30
February 2014 Vol 7, No 1, Special Issue ASH 2013 Payers' Perspectives in Oncology
32
February 2015 Vol 8, No 1
4
February 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
26
February 2016 Vol 9, No 1
6
February 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology
18
February 2017 Vol 10, No 1
6
February 2017 Vol 10, Special Issue: Payers’ Perspectives In Oncology: ASH 2016 Highlights
27
February 2018 Vol 11, No 1
5
February 2019 Vol 12, No 1
7
February 2019, Vol 12, No 1, Supplement 1: Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective
1
February 2019, Vol 12, No 1, Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
1
February 2020 Vol 13, No 1
3
February 2020 Vol 13, Special Issue: Payers' Perspectives in Oncology
26
February 2021 Vol 14, Special Issue: Payers' Perspectives in Oncology
27
February/March 2009, Vol 2, No 2
6
January 2009, Vol 2, No 1
7
January/February 2010, Vol 3, No 1
7
January/February 2011, Vol 4, No 1
6
January/February 2012, Vol 5, No 1
6
January/February 2013 Vol 6, No 1
8
January/February 2014 Vol 7, No 1
5
January/February 2019, Vol 12, Special Issue: Payers’ Perspectives in Oncology: ASH 2018 Highlights
24
July 2012, Vol 5, No 4
5
July 2013 Vol 6, No 5
7
July 2016 Vol 9, No 5
4
July 2017 Vol 10, No 5
5
July 2017, Supplement - Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
4
July 2018 Vol 11, No 5
4
July/August 2008, Vol 1, No 6
10
July/August 2010, Vol 3, No 4
8
July/August 2011, Vol 4, No 4
6
July/August 2012, Vol 5, No 5
6
July/August 2013 Vol 6, No 6
5
July/August 2015 Vol 8 No 5
6
June 2008, Vol 1, No 5
6
June 2014 Vol 7, No 4
5
June 2015, Vol 8, No 4
6
June 2016 Vol 9, No 4
5
June 2017 Vol 10, No 4
5
June 2018 Vol 11, No 4
6
June 2020 Vol 13, No 3
7
June 2021 Vol 14, No 2
6
June 2022 Vol 15, No 2
3
June 2023 Vol 16, No 1
5
June/July 2009, Vol 2, No 4
11
June/July 2019 Vol 12, No 4
6
March 2008, Vol 1, No 2
8
March 2015, Vol 8, Sixth Annual Payers' Guide
27
March 2016, Supplement - Conquering COPD: Value-Based Perspectives for Providers and Payers
0
March 2016, Vol 9, Seventh Annual Payers' Guide
43
March 2017, Vol 10, Eighth Annual Payers' Guide
14
March 2018, Supplement - Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
4
March 2018, Vol 11, Ninth Annual Payers' Guide
31
March 2019, Vol 12, Tenth Annual Payers' Guide
17
March 2021 Vol 14, No 1
4
March 2022 Vol 15, No 1 - Online Only
4
March/April 2010, Vol 3, No 2
10
March/April 2011, Vol 4, No 2
7
March/April 2012, Vol 5, No 2
4
March/April 2013 Vol 6, No 2
6
May 2008, Vol 1, No 4
13
May 2010, Vol 3, No 3, SPECIAL ISSUE
0
May 2014 Vol 7, No 3
7
May 2015, Vol 8, No 3
5
May 2016 Vol 9, No 3
6
May 2017 Vol 10, No 3
5
May 2018 Vol 11, No 3
4
May 2019 Vol 12, No 3
4
May 2020 Vol 13, No 2
5
May/June 2010, Vol 3, No 3
13
May/June 2011, Vol 4, No 3
9
May/June 2012, Vol 5, No 3
9
May/June 2013 Vol 6, No 4
8
November 2014 Vol 7, No 8
5
November 2015 Vol 8, No 8
5
November 2016 Vol 9, No 8
5
November 2017 Vol 10, No 8
4
November 2018 Vol 11, No 8
5
November 2019 Vol 12, No 7
5
November/December 2008, Vol 1, No 9
10
November/December 2009, Vol 2, No 7
7
November/December 2010, Vol 3, No 6
12
November/December 2011, Vol4, No7
5
November/December 2012 Vol 5, No 7
8
November/December 2013, Vol 6, No 9
8
October 2008, Vol 1, No 8
7
October 2014 Vol 7, No 6
0
October 2014 Vol 7, No 7
5
October 2015 Vol 8, No 7
5
October 2016 Vol 9, No 7
4
October 2017 Vol 10, No 7
3
October 2018 Vol 11, No 7
5
October 2019 Vol 12, No 6
5
October/November 2020 Vol 13, No 5
10
Online First
0
Payer Perspectives in Dermatology
25
September 2008, Vol 1, No 7
9
September 2011, Vol 4, No 5
6
September 2013, Vol 6, No 7
6
September 2014 Vol 7, No 6
4
September 2015 Vol 8, No 6
6
September 2016 Vol 9, No 6
5
September 2017 Vol 10, No 6
4
September 2018 Vol 11, No 6
4
September 2019 Vol 12, No 5
6
September 2020 Vol 13, No 4
6
September 2022 Vol 15, No 3
3
September/October 2009, Vol 2, No 6
7
September/October 2010, Vol 3, No 5
6
September/October 2011 Volume 4, Number 6
10
September/October 2012 Vol 5, No 6
7
September/October 2013, Vol 6, No 8
6
Special Feature Fifth Annual Payers' Guide to New FDA Approvals March 2014 Volume 7
33
Supplements
41
Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2
34
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
24
Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1
30
Videos
95
Web Exclusives
340
SUBSCRIBE
© Amplity Health. All rights reserved.